Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents - Wikidata - wikimedia - TriplyDB

Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents

Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents

http://www.wikidata.org/entity/Q35072975

about

Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination Very early combination antiretroviral therapy in infants: prospects for cure Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy HIV-exposed children account for more than half of 24-month mortality in Botswana.Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.Infectious Diseases of Poverty in Children: A Tale of Two Worlds Paediatric HIV: Progress on Prevention, Treatment and Cure Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children.Advances and hope for perinatal HIV remission and cure in children and adolescents.Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain Predictors of Infant Age at Enrollment in Early Infant Diagnosis Services in Kenya.International AIDS Society global scientific strategy: towards an HIV cure 2016.Immediate access to antiretroviral therapy is important in children living with HIV.The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children.Developments in early diagnosis and therapy of HIV infection in newborns.Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression.Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.Antiretroviral treatment for HIV infection: Swedish recommendations 2016.Early sites of virus replication after oral SIVmac251 infection of infant macaques: implications for pathogenesis.The microbiome and HIV persistence: implications for viral remission and cure.Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children HIV control: Is getting there the same as staying there?

P2860

Q26776518-C53D2F26-71E6-4541-974C-6D014763F067 Q26830063-F15AE7BC-E04D-43DF-9997-99A295D57365 Q35962423-C5D9307C-FC12-452D-B023-55813016E455 Q35996827-C8264F43-A200-4501-8AF0-4D9DD94E705C Q36030494-75701752-C4D3-4B8F-8B9E-14E6A17A57A5 Q36083089-B57895D4-BBDE-4A4B-915A-4F50638817D5 Q36274030-E13A1347-8A4B-46D8-86EB-4B90A06F29A0 Q36328026-F37087DD-F515-496D-9705-FC919DCA1CBB Q36395153-E789FF17-EED3-4E19-9D1F-67AF95104C76 Q36509571-BDB0AA0C-4E45-49F8-9997-F0F7B0B67735 Q36737063-AE8B2020-23F5-4FFA-8421-05A848E895DD Q37098390-EDA39498-5FF7-4972-B2C8-645DD43C3DC7 Q37198242-ACBC7585-AAA3-48D1-837A-900663D304B1 Q37661770-A66FBF52-F089-4479-845B-B8353D688FC9 Q37704932-CAF55ED2-6100-4315-A28F-CF615C999604 Q38505356-9CD0BD9A-BFBC-4B35-87C5-07CCDEC97C38 Q38648601-84A7A961-B2D0-4082-B9E9-73BE5AFAFCC2 Q38776093-992016B2-21C1-4B8B-93FC-C091588E350C Q38936786-D88E1D85-008C-47A8-836E-DBB8DBF5C3A4 Q40158843-D21ED2BC-189D-487A-9E65-2ADE6FC5175C Q40470257-6042E86E-5483-4EDF-84CA-9B7712832F36 Q46046314-40747487-BCD6-4EF5-B633-6ABEC156A941 Q47580980-4422A629-0B9F-48CD-A344-EBA1B6B28404 Q53681956-10E09D32-1A37-41F8-A298-4D3F5EC4C0FD Q56969729-DA3E556D-F909-4516-A626-05ACBD90A0E2 Q57140492-645A692D-0651-4E94-8D5F-BE061962108E Q58085173-888470E6-287E-45C5-B4C4-BADC876C4E55

P2860

Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents

http://www.wikidata.org/entity/Q35072975

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Influence of age at virologic ...... rinatally infected adolescents

@ast

Influence of age at virologic ...... rinatally infected adolescents

@en

type

label

Influence of age at virologic ...... rinatally infected adolescents

@ast

Influence of age at virologic ...... rinatally infected adolescents

@en

prefLabel

Influence of age at virologic ...... rinatally infected adolescents

@ast

Influence of age at virologic ...... rinatally infected adolescents

@en

P1433

Q35072975-E869385C-CA19-4584-A3C8-5A45DDC6D8E6

P1476

Q35072975-5688EAC6-EA61-4195-B853-327AD7D30808

P2093

Q35072975-00F849FF-8B3E-4DA2-8B3B-8CE69A48B3CA

Q35072975-0E0575B4-56FB-43B1-9729-A5CA1A3C5071

Q35072975-25BF3079-9112-4D83-B82E-55CEFCC83AF4

Q35072975-28AEBF09-FA26-4291-9BD0-277F90562624

Q35072975-293C9AC2-D74B-4138-9AC9-7EAE4D88509D

Q35072975-35F6FD56-388B-4393-A7EC-E86C322AB4CC

Q35072975-38D7E56E-AF3C-4DB8-910D-C65DA9FB1EEA

Q35072975-8C9298D2-FCD2-483E-AF1E-87C420FD3713

Q35072975-AC8779FB-0DC9-4520-AA56-1938337C50C6

Q35072975-AE72EE04-67BA-4706-B4EC-72F0379FAF7A

P2860

Q35072975-0B964A41-5BE8-4C36-8FF6-CE2165F92E74

Q35072975-0D43C4E4-AB67-47DF-913D-CFFDD3A706E0

Q35072975-132FEE1A-D2F8-493C-B151-8F5E59414634

Q35072975-251E004F-60D5-4B79-829E-36FC77B69D2A

Q35072975-2E2C6767-08DB-4DF9-A6AD-50F78B92BFCF

Q35072975-31908130-3CAE-432D-9B49-90B61FAE9C89

Q35072975-3ABC8DDA-7850-4532-BC81-EC720600D180

Q35072975-3CD52568-3F5A-4532-A041-86D5FF983FF1

Q35072975-59D1135D-4866-45B6-B0B4-7DA190A4B673

Q35072975-5B19A275-4CC3-436A-84B5-F1B27A4BBF6D

P304

Q35072975-04A98788-033B-47F4-9BFB-8ADF7048970D

P31

Q35072975-988E4E65-03D8-4157-B425-D6AC40E0C41A

P356

Q35072975-04C5FF8B-28C3-4AA2-B24D-32B1708598C5

P407

Q35072975-70ECBC79-59A6-48B6-960F-F0E486C4DDDA

P433

Q35072975-9AF85902-C5B8-4E3B-8C7A-EED70616E352

P478

Q35072975-D8C91233-7AA0-499F-BCC5-8C82ADEDBFAD

P50

Q35072975-E1E7B6EB-4CBC-46E0-8956-C35EEB85DB2A

P577

Q35072975-0781AA76-B40E-4A46-A8B7-BD27F497F6A2

P698

Q35072975-A10F038E-CBB9-45CC-A01B-BECF1082D359

P921

Q35072975-088808D1-2B69-4307-92EB-E99D4D9637B4

P932

Q35072975-339E9D03-6D75-4E2E-8C58-D1BE1840CC28

P356

JAMAPEDIATRICS.2014.1560

P1433

JAMA Pediatrics

P1476

Influence of age at virologic ...... rinatally infected adolescents

@en

P2093

Angela Ellis

http://www.w3.org/2001/XMLSchema#string

Brad Karalius

http://www.w3.org/2001/XMLSchema#string

Carrie Ziemniak

http://www.w3.org/2001/XMLSchema#string

Deborah Persaud

http://www.w3.org/2001/XMLSchema#string

Douglas Richman

http://www.w3.org/2001/XMLSchema#string

George K Siberry

http://www.w3.org/2001/XMLSchema#string

George R Seage

http://www.w3.org/2001/XMLSchema#string

Katherine Luzuriaga

http://www.w3.org/2001/XMLSchema#string

Kunjal Patel

http://www.w3.org/2001/XMLSchema#string

Pediatric HIV/AIDS Cohort Study

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

The challenge of viral reservoirs in HIV-1 infection

The end of AIDS: HIV infection as a chronic disease

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events.

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

P304

1138-1146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAPEDIATRICS.2014.1560

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Kaitlin Rainwater-Lovett

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25286283

http://www.w3.org/2001/XMLSchema#string

P921

P932

4324476

http://www.w3.org/2001/XMLSchema#string